Forbes Japan "100 Japanese Startups to Watch in 2026"

We are thrilled to share that FerroptoCure has been selected by Forbes JAPAN as one of the “100 Japanese Startups to Watch in 2026” in the startup feature of the January 2026 issue (released November 25, 2025). Driven by a strong passion to change the future of cancer care, we remain committed to advancing next‑generation ferroptosis‑inducing cancer therapies and bringing new options to patients around the world.